85 related articles for article (PubMed ID: 2547954)
21. Detection of simian immunodeficiency virus in macaque lymph nodes with a SIVmac envelope probe.
Wyand MS; Ringler DJ; Mattmuller M; Daniel MD; Desrosiers RC; King NW
J Med Primatol; 1989; 18(3-4):209-15. PubMed ID: 2547958
[TBL] [Abstract][Full Text] [Related]
22. Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus.
Chakrabarti L; Baptiste V; Khatissian E; Cumont MC; Aubertin AM; Montagnier L; Hurtrel B
Virology; 1995 Nov; 213(2):535-48. PubMed ID: 7491778
[TBL] [Abstract][Full Text] [Related]
23. Productive infection of dendritic cells by simian immunodeficiency virus in macaque intestinal tissues.
Choi YK; Whelton KM; Mlechick B; Murphey-Corb MA; Reinhart TA
J Pathol; 2003 Dec; 201(4):616-28. PubMed ID: 14648666
[TBL] [Abstract][Full Text] [Related]
24. CDC warns researchers.
Occup Health Saf; 1989 Mar; 58(3):17. PubMed ID: 2540468
[No Abstract] [Full Text] [Related]
25. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks.
Sodora DL; Gettie A; Miller CJ; Marx PA
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S119-23. PubMed ID: 9581895
[TBL] [Abstract][Full Text] [Related]
26. Transmission of the simian immunodeficiency virus SIVmne in macaques and baboons.
Morton WR; Kuller L; Benveniste RE; Clark EA; Tsai CC; Gale MJ; Thouless ME; Overbaugh J; Katze MG
J Med Primatol; 1989; 18(3-4):237-45. PubMed ID: 2547959
[TBL] [Abstract][Full Text] [Related]
27. Permissiveness of Kupffer cells for simian immunodeficiency virus (SIV) and morphological changes in the liver of rhesus monkeys at different periods of SIV infection.
Persidsky Y; Steffan AM; Gendrault JL; Hurtrel B; Berger S; Royer C; Stutte HJ; Muchmore E; Aubertin AM; Kirn A
Hepatology; 1995 May; 21(5):1215-25. PubMed ID: 7737626
[TBL] [Abstract][Full Text] [Related]
28. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
[TBL] [Abstract][Full Text] [Related]
29. [Classification of microscopic fungi from the aspect of risk of infection in laboratory personnel].
Volleková A; Tomsíková A
Epidemiol Mikrobiol Imunol; 1998 Dec; 47(4):154-8. PubMed ID: 9919817
[TBL] [Abstract][Full Text] [Related]
30. [The immunological manifestations and cytological characteristics of infection caused by the simian immunodeficiency virus (SIV) in rhesus monkeys].
Persidskiĭ IuV; Shcherbinskaia AM; Barshteĭn IuA; Antonenko SV; Marichev IL
Tsitol Genet; 1993; 27(6):97-104. PubMed ID: 8066812
[TBL] [Abstract][Full Text] [Related]
31. Biosafety considerations in handling medically important fungi.
Padhye AA; Bennett JE; McGinnis MR; Sigler L; Fliss A; Salkin IF
Med Mycol; 1998; 36 Suppl 1():258-65. PubMed ID: 9988515
[TBL] [Abstract][Full Text] [Related]
32. Safety: protecting laboratory workers.
Piney M
Occup Health (Lond); 1979 Jul; 31(7):360-3. PubMed ID: 257243
[No Abstract] [Full Text] [Related]
33. Unions press for urgent action on lethal viruses.
Nurs Mirror; 1979 Jan; 148(2):7. PubMed ID: 252741
[No Abstract] [Full Text] [Related]
34. Pros and cons of vaccinia immunization.
J Occup Med; 1992 Aug; 34(8):757. PubMed ID: 1324299
[No Abstract] [Full Text] [Related]
35. [Epidemiology and prevention of tuberculous contamination in bacteriology laboratories. Results of a survey on 23 laboratories].
Carbonnelle B; Carbonnelle P; Fruchart A; Dugimont JC; Tison F
Rev Epidemiol Med Soc Sante Publique; 1975; 23(7-8):417-28. PubMed ID: 1227160
[TBL] [Abstract][Full Text] [Related]
36. Counselling of workers handling vaccinia virus.
Williams NR; Cooper BM
Occup Med (Lond); 1993 Aug; 43(3):125-7. PubMed ID: 8400205
[TBL] [Abstract][Full Text] [Related]
37. [Biosafety in the laboratory].
Ishak R; Linhares AC; Ishak MO
Rev Inst Med Trop Sao Paulo; 1989; 31(2):126-31. PubMed ID: 2602803
[TBL] [Abstract][Full Text] [Related]
38. Laboratory management of agents associated with hantavirus pulmonary syndrome: interim biosafety guidelines. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1994 May; 43(RR-7):1-7. PubMed ID: 8202073
[TBL] [Abstract][Full Text] [Related]
39. Teaching safety management guidelines.
Bachner P
Am J Clin Pathol; 1991 Oct; 96(4):557. PubMed ID: 1892129
[No Abstract] [Full Text] [Related]
40. Laboratory safety.
Taylor CE; Williams EW; Newsom SW; Rampling AM; Boissard JM; McNeice VA; Nagington J; Walker JR; Warren RE; Wreghitt TG; Brown DF; Fell HW; Gostling JV; Lacey RW; Pilsworth R; Rycroft JA; Andrews BE; Shepherd W; Thomas CG; Yaneza AL
Lancet; 1980 Jan; 1(8159):101. PubMed ID: 6101403
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
